Clinical Trials Sponsored by Schering SA

Total 1227 results

French Innovative Leukemia Organisation
Novartis; Schering SA

Completed

GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly

Acute Myeloid Leukemia

France
Schering-Plough

Withdrawn

A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)

Myocardial Infarction | Coronary Disease

United States, France, Canada
Schering-Plough

Completed

A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)

Nausea | Vomiting
Schering-Plough

Completed

Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

Hepatitis C, Chronic | Hepacivirus
Schering-Plough

Completed

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Hepatitis C, Chronic
Schering-Plough

Terminated

Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)

Perennial Allergic Rhinitis
Schering-Plough

Completed

Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)

Hypertension
Novartis
Schering-Plough

Completed

Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma

Asthma

United States, Colombia, Peru
Novacea
Schering-Plough

Suspended

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Novartis
Schering-Plough

Completed

A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

France, Germany, Belgium, Italy, Turkey, Hungary, Argentina, Peru, United Kingdom, South Africa, Latvia, Lithuania, Romania, Chile, Ireland, Norway, Poland
Novartis
Schering-Plough

Completed

Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers

Healthy

United Kingdom
UConn Health
Schering-Plough

Terminated

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

Ovarian Hyperstimulation Syndrome | Endometrial Receptivity

United States
Centocor, Inc.
Schering-Plough

Completed

An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy

Arthritis, Rheumatoid

Australia, Poland, Ukraine, United States, Argentina, Colombia, Mexico, Korea, Republic of, Malaysia, Russian Federation, New Zealand, Hungary, Lithuania
Centocor, Inc.
Schering-Plough

Completed

Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

China
Creighton University
Schering-Plough

Completed

Mometasone and Markers of Airway Inflammation

Asthma

United States
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Rheumatoid Arthritis

United States, Australia, Poland, Ukraine, United Kingdom, Taiwan, Spain, Argentina, Belgium, India, Korea, Republic of, Canada, Singapore, Russian Federation, Chile, Austria, New Zealand, Thailand, Hungary, Philippines, Malaysia
Centocor, Inc.
Schering-Plough

Completed

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Australia, Poland, Ukraine, United States, Argentina, Colombia, New Zealand, Peru, Mexico, Germany, Hungary, Lithuania, Malaysia, Latvia, Malta
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

Arthritis, Rheumatoid

United States, Australia, United Kingdom, Germany, Spain, Canada, Finland, Austria, New Zealand, Netherlands
Marmara University
Schering-Plough

Completed

Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

Glioblastoma | Astrocytoma | Oligodendroglioma | Brain Tumor, Recurrent

Turkey
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

Spondylitis, Ankylosing

United States, Germany, Finland, Taiwan, Korea, Republic of, Canada, Belgium, Netherlands, France
Duke University
Schering-Plough

Completed

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Glioblastoma | Gliosarcoma | Anaplastic Astrocytoma

United States
Monash University
Schering-Plough

Withdrawn

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study (ACCESS)

Hypertension

Australia
Bayer
GlaxoSmithKline; Schering-Plough

Completed

Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

Belgium, Spain, Germany, South Africa, France, Netherlands
Bayer
GlaxoSmithKline; Schering-Plough

Completed

Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.

Erectile Dysfunction

Canada, United States, Australia, Mexico
Centocor, Inc.
Schering-Plough

Completed

An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (GO-FORWARD)

Rheumatoid Arthritis

Australia, Poland, United States, Germany, Argentina, Canada, Korea, Republic of, Chile, New Zealand, Taiwan, Mexico, Hungary
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis (GO-REVEAL)

Arthritis, Psoriatic

United States, Poland, United Kingdom, Spain, Canada, Belgium
Arbeitsgemeinschaft medikamentoese Tumortherapie
Schering-Plough

Completed

A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response

B-cell Chronic Lymphocytic Leukemia

Austria
Asan Medical Center
Schering-Plough

Completed

Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Korea, Republic of
University College, London
Schering-Plough

Completed

The Role of Dendritic Cells in Hepatitis C Infection

Chronic Hepatitis C Infection

United Kingdom
Sankom SA
InterMedService SA; Pharmaxi LLC

Unknown

Study to Evaluate Impact SANKOM Patent Socks in Patients With CVI

Chronic Venous Insufficiency

Ukraine
University of Pittsburgh
Schering-Plough

Completed

Melanoma Molecular Profiling Analysis

Melanoma

United States
Johns Hopkins University
Schering-Plough

Terminated

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

Asthma

United States
University of Pittsburgh
Schering-Plough

Terminated

Pilot Study of IFN α2b for Melanoma Patients

Melanoma

United States
University of Utah
Schering-Plough

Terminated

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

Gastrointestinal Stromal Tumors | Solid Tumors | Cancer Brain

United States
Novartis Pharmaceuticals
Schering-Plough

Completed

A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

Asthma

Russian Federation, United Kingdom, Germany, Spain, Czech Republic, Israel, Poland, South Africa, Belgium, Hungary
Innovaderm Research Inc.
Schering-Plough

Completed

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Palmoplantar Psoriasis

Canada
University Hospital, Bordeaux
Schering-Plough

Completed

PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) (EADO)

Melanoma | Neoplasm Metastasis

France
University of Wuerzburg
Schering-Plough

Completed

Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Germany
University of Pittsburgh
Schering-Plough

Terminated

Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095

Fungal Infection

United States
Teoxane SA

Recruiting

TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults

Nasolabial Folds

China
Aktiia SA

Not yet recruiting

Evaluation of the Satisfaction of a Hypertensive Population in Their Use of the Aktiia 24/7 Blood Pressure Monitor (OBPM_HTN2024)

Hypertension
Aesyra SA

Recruiting

Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity

Sleep Bruxism

Italy
Teoxane SA

Recruiting

Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face (LIFTUP)

Aging | Chin Retrusion

Switzerland
Stalicla SA

Recruiting

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Autism Spectrum Disorder

United States, Spain, Australia
Distalmotion SA

Recruiting

Robotic MIS With Dexter

Hysterectomy | Partial Nephrectomy | Right Colectomy

Switzerland, France, Germany
Regenosca SA

Recruiting

Bioengineered Collagen Implant for Urethral Stricture Repair

Urethral Stricture

Malaysia
Poxel SA

Not yet recruiting

Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)

ALD (Adrenoleukodystrophy)
Sintetica SA

Recruiting

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Hernia, Inguinal | Flat Foot

Italy, Spain
Novigenix SA

Completed

Relapse Markers for Colorectal Cancer (RELMA-C)

Colorectal Cancer

Belgium
Imcyse SA

Active, not recruiting

IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study (IMCY-MS-001)

Multiple Sclerosis, Relapsing-Remitting

Moldova, Republic of

Clinical Trials Sponsored by Schering SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations